The Census Bureau will release its latest snapshot of poverty, income and health insurance tomorrow. The numbers without health insurance are expected to rise sharply. Helen Palmer reports.
Merck is looking to replace its once-popular painkiller Vioxx with a new drug called Arcoxia. But after all the Vioxx lawsuits, are consumers game to try it? Helen Palmer reports.
A biotech company claims it can create embryonic stem cells without destroying embryos. But that still might not be enough to entice investors. Helen Palmer reports.
About 4,500 women have filed lawsuits against Wyeth for failing to warn them of cancer risks from its menopause drug Prempro that were found in a 2001 study. The first of those cases goes to trial tomorrow. Helen Palmer reports.
Drug maker Bristol Myers Squibb is in court trying to stop a Canadian company from selling a generic version of its blockbuster blood-thinning drug. Helen Palmer reports.
The cost to care for stroke victims is expected to reach $2.2 trillion over the next 45 years. Doctors are calling for more government cash to halt what they call an impending epidemic. Helen Palmer reports.
Laid-off Northwest Airlines workers got something from the company this week: a booklet called "101 Ways to Save Money." Helen Palmer tells us why many of the workers are less than appreciative.
A report out today finds that a new drug called Chantix helps smokers kick the habit. The maker of the drug paid for the studies, but it's not necessarily a conflict of interest, reports Helen Palmer.
Defibrillators are popping up in public places everywhere these days, but a new report says one in five could be defective. Helen Palmer looks into the life-saving market.
